These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 8681438
1. Selective dieldrin promotion of hepatic focal lesions in mice. Kolaja KL, Stevenson DE, Walborg EF, Klaunig JE. Carcinogenesis; 1996 Jun; 17(6):1243-50. PubMed ID: 8681438 [Abstract] [Full Text] [Related]
2. Reversibility of promoter induced hepatic focal lesion growth in mice. Kolaja KL, Stevenson DE, Walborg EF, Klaunig JE. Carcinogenesis; 1996 Jul; 17(7):1403-9. PubMed ID: 8706241 [Abstract] [Full Text] [Related]
3. Vitamin E modulation of dieldrin-induced hepatic focal lesion growth in mice. Kolaja KL, Xu Y, Walborg EF, Stevenson DE, Klaunig JE. J Toxicol Environ Health A; 1998 Mar 27; 53(6):479-92. PubMed ID: 9537283 [Abstract] [Full Text] [Related]
4. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Kolaja KL, Stevenson DE, Walborg EF, Klaunig JE. Carcinogenesis; 1996 May 27; 17(5):947-54. PubMed ID: 8640942 [Abstract] [Full Text] [Related]
5. Vitamin E modulation of hepatic focal lesion growth in mice. Kolaja KL, Klaunig JE. Toxicol Appl Pharmacol; 1997 Apr 27; 143(2):380-7. PubMed ID: 9144454 [Abstract] [Full Text] [Related]
6. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Kolaja KL, Stevenson DE, Johnson JT, Walborg EF, Klaunig JE. Fundam Appl Toxicol; 1996 Feb 27; 29(2):219-28. PubMed ID: 8742319 [Abstract] [Full Text] [Related]
7. Cell proliferation and regulation of negative growth factors in mouse liver foci. Moser GJ, Wolf DC, Harden R, Standeven AM, Mills J, Jirtle RL, Goldsworthy TL. Carcinogenesis; 1996 Sep 27; 17(9):1835-40. PubMed ID: 8824503 [Abstract] [Full Text] [Related]
8. Inhibition of tumor promotion and hepatocellular growth by dietary restriction in mice. Kolaja KL, Bunting KA, Klaunig JE. Carcinogenesis; 1996 Aug 27; 17(8):1657-64. PubMed ID: 8761422 [Abstract] [Full Text] [Related]
9. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay. Ou YC, Conolly RB, Thomas RS, Xu Y, Andersen ME, Chubb LS, Pitot HC, Yang RS. Cancer Res; 2001 Mar 01; 61(5):1879-89. PubMed ID: 11280742 [Abstract] [Full Text] [Related]
10. Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis. La Porta CA, Comolli R. Carcinogenesis; 1995 May 01; 16(5):1233-8. PubMed ID: 7767990 [Abstract] [Full Text] [Related]
11. Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone. Isenberg JS, Kolaja KL, Ayoubi SA, Watkins JB, Klaunig JE. Carcinogenesis; 1997 Aug 01; 18(8):1511-9. PubMed ID: 9276624 [Abstract] [Full Text] [Related]
12. Inhibitory effect of dietary iron deficiency on the induction of putative preneoplastic foci in rat liver initiated with diethylnitrosamine and promoted by phenobarbital. Yoshiji H, Nakae D, Kinugasa T, Matsuzaki M, Denda A, Tsujii T, Konishi Y. Br J Cancer; 1991 Nov 01; 64(5):839-42. PubMed ID: 1681886 [Abstract] [Full Text] [Related]
13. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats. LeBoeuf RA, Laishes BA, Hoekstra WG. Cancer Res; 1985 Nov 01; 45(11 Pt 1):5489-95. PubMed ID: 2865004 [Abstract] [Full Text] [Related]
14. Role of oxidative stress in the selective toxicity of dieldrin in the mouse liver. Bachowski S, Xu Y, Stevenson DE, Walborg EF, Klaunig JE. Toxicol Appl Pharmacol; 1998 Jun 01; 150(2):301-9. PubMed ID: 9653061 [Abstract] [Full Text] [Related]
15. Comparative effects of dieldrin on hepatic ploidy, cell proliferation, and apoptosis in rodent liver. Kamendulis LM, Kolaja KL, Stevenson DE, Walborg EF, Klaunig JE. J Toxicol Environ Health A; 2001 Jan 26; 62(2):127-41. PubMed ID: 11209821 [Abstract] [Full Text] [Related]
16. Effect of dietary retinyl palmitate on the promotion of altered hepatic foci by 3,3',4,4'-tetrachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl in rats initiated with diethylnitrosamine. Berberian I, Chen LC, Robinson FR, Glauert HP, Chow CK, Robertson LW. Carcinogenesis; 1995 Feb 26; 16(2):393-8. PubMed ID: 7859372 [Abstract] [Full Text] [Related]
17. Diethylnitrosamine exposure-responses for DNA ethylation, hepatocellular proliferation, and initiation of carcinogenesis in rat liver display non-linearities and thresholds. Williams GM, Iatropoulos MJ, Jeffrey AM, Luo FQ, Wang CX, Pittman B. Arch Toxicol; 1999 Sep 26; 73(7):394-402. PubMed ID: 10550482 [Abstract] [Full Text] [Related]
18. Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice. Kushida M, Kamendulis LM, Peat TJ, Klaunig JE. Toxicol Pathol; 2011 Aug 26; 39(5):776-86. PubMed ID: 21628716 [Abstract] [Full Text] [Related]
19. Selective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbital. Klaunig JE. Environ Health Perspect; 1993 Dec 26; 101 Suppl 5(Suppl 5):235-9. PubMed ID: 8013413 [Abstract] [Full Text] [Related]
20. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Tanaka T, Kojima T, Kawamori T, Yoshimi N, Mori H. Cancer Res; 1993 Jun 15; 53(12):2775-9. PubMed ID: 8504418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]